Search

Author/Creator Lechmann, Martin

1. Characterization of a re‐engineered, mesothelin‐targeted Pseudomonas exotoxin fusion protein for lung cancer therapy. Issue 8 (14th July 2016)

Authors:
Bauss, Frieder; Lechmann, Martin; Krippendorff, Ben-Fillippo; Staack, Roland; Herting, Frank; Festag, Matthias; Imhof-Jung, Sabine; Hesse, Friederike; Pompiati, Marc; Kollmorgen, Gwendlyn; da Silva Mateus Seidl, Rita; Bossenmaier, Birgit; Lau, Wilma; Schantz, Christian; Stracke, Jan O.; Brinkmann...
Journal:
Molecular oncology
Issue:
Volume 10:Issue 8(2016:Oct.)
Page Start:
1317
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. The impact of immunogenicity on therapeutic antibody pharmacokinetics: A preclinical evaluation of the effect of immune complex formation and antibody effector function on clearance. Issue 1 (1st January 2021)

Authors:
Opolka-Hoffmann, Eugenia; Jordan, Gregor; Otteneder, Michael; Kieferle, Robin; Lechmann, Martin; Winter, Gerhard; Staack, Roland F.
Journal:
MAbs
Issue:
Volume 13:Issue 1(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Translating pharmacology models effectively to predict therapeutic benefit. Issue 6 (June 2022)

Authors:
Dudal, Sherri; Bissantz, Caterina; Caruso, Antonello; David-Pierson, Pascale; Driessen, Wouter; Koller, Erich; Krippendorff, Ben-Fillippo; Lechmann, Martin; Olivares-Morales, Andrés; Paehler, Axel; Rynn, Caroline; Türck, Dietrich; Van De Vyver, Arthur; Wang, Ken; Winther, Lotte
Journal:
Drug discovery today
Issue:
Volume 27:Issue 6(2022)
Page Start:
1604
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗